Profiles

Keywords
Last Name
Institution

Giselle Mosnaim

Concepts (214)

Concepts are derived automatically from a person's publications.

Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.

Name Number of Publications Most Recent Publication Publications by All Authors Concept Score Why?
Asthma
41
2021
176
11.990
Why?
Anti-Asthmatic Agents
14
2021
35
3.480
Why?
Telemedicine
6
2021
83
3.030
Why?
Patient Education as Topic
9
2021
191
2.830
Why?
Adrenal Cortex Hormones
9
2021
99
2.600
Why?
Physicians
5
2020
112
2.470
Why?
Coronavirus Infections
7
2020
97
2.430
Why?
Pneumonia, Viral
7
2020
104
2.420
Why?
Hypersensitivity
5
2020
52
2.150
Why?
Medication Adherence
8
2021
87
2.140
Why?
Hispanic Americans
8
2021
218
2.090
Why?
Burnout, Professional
3
2020
38
1.920
Why?
Child
27
2021
1505
1.580
Why?
Community Health Workers
6
2021
33
1.540
Why?
Pandemics
9
2021
148
1.320
Why?
Caregivers
7
2019
140
1.290
Why?
Behavior Therapy
2
2017
83
1.270
Why?
Humans
57
2021
29841
1.190
Why?
Emergency Service, Hospital
8
2020
165
1.050
Why?
Mobile Applications
2
2020
33
1.040
Why?
Adolescent
20
2021
2591
0.990
Why?
Environmental Exposure
2
2018
13
0.910
Why?
Allergy and Immunology
4
2020
5
0.900
Why?
Monitoring, Ambulatory
1
2020
23
0.890
Why?
Poverty
3
2020
98
0.860
Why?
Administration, Inhalation
9
2021
35
0.810
Why?
Parents
2
2018
100
0.780
Why?
Emigrants and Immigrants
2
2018
25
0.780
Why?
Respiratory Tract Diseases
1
2018
8
0.770
Why?
Physician-Patient Relations
1
2018
47
0.760
Why?
Registries
1
2019
195
0.730
Why?
Self Care
5
2020
107
0.710
Why?
African Americans
3
2017
739
0.690
Why?
Decision Making
1
2018
222
0.670
Why?
Assertiveness
1
2015
9
0.650
Why?
Urban Population
5
2013
155
0.590
Why?
Female
28
2021
17657
0.570
Why?
Chicago
7
2019
916
0.560
Why?
Male
27
2021
17153
0.540
Why?
Health Literacy
3
2020
91
0.540
Why?
Social Support
2
2021
215
0.540
Why?
Family
3
2021
97
0.530
Why?
Minority Groups
4
2019
69
0.520
Why?
MP3-Player
2
2013
4
0.520
Why?
Patient Compliance
2
2011
201
0.500
Why?
House Calls
3
2021
15
0.490
Why?
Nebulizers and Vaporizers
3
2021
18
0.470
Why?
Computer Security
2
2020
10
0.450
Why?
Insurance, Health, Reimbursement
2
2020
15
0.450
Why?
Stress Disorders, Post-Traumatic
4
2021
201
0.430
Why?
Socioeconomic Factors
5
2021
351
0.430
Why?
Child, Preschool
7
2021
785
0.420
Why?
Asthma, Exercise-Induced
1
2009
1
0.410
Why?
Health Knowledge, Attitudes, Practice
2
2011
223
0.410
Why?
Adrenergic beta-Agonists
1
2009
21
0.410
Why?
Athletes
1
2009
70
0.380
Why?
Communication Barriers
1
2007
9
0.380
Why?
Adaptation, Psychological
2
2020
170
0.370
Why?
Language
1
2007
76
0.350
Why?
Quality Improvement
3
2018
169
0.340
Why?
Hospitalization
2
2020
330
0.340
Why?
Research Design
2
2019
227
0.330
Why?
Adult
12
2021
9591
0.310
Why?
Electronic Health Records
3
2020
72
0.300
Why?
Bronchodilator Agents
2
2021
13
0.280
Why?
Severity of Illness Index
5
2021
1220
0.270
Why?
Glucocorticoids
2
2020
75
0.260
Why?
Delivery of Health Care
2
2020
110
0.250
Why?
Biomedical Technology
1
2021
9
0.240
Why?
Endpoint Determination
1
2021
31
0.230
Why?
Cross-Sectional Studies
6
2021
915
0.230
Why?
Electronics
1
2020
16
0.230
Why?
Mental Health
2
2020
103
0.230
Why?
Feedback
1
2020
26
0.230
Why?
Remote Sensing Technology
1
2020
3
0.230
Why?
Comparative Effectiveness Research
2
2021
9
0.230
Why?
Confidentiality
1
2020
11
0.230
Why?
Adrenergic beta-2 Receptor Agonists
1
2020
3
0.230
Why?
Clinical Coding
1
2020
8
0.230
Why?
Albuterol
3
2021
17
0.220
Why?
Desensitization, Immunologic
1
2020
6
0.220
Why?
Lung
1
2021
164
0.220
Why?
Ambulatory Care Facilities
1
2020
39
0.210
Why?
United States
4
2020
2402
0.210
Why?
Fellowships and Scholarships
1
2020
35
0.210
Why?
Delivery of Health Care, Integrated
1
2020
30
0.210
Why?
Family Relations
1
2019
13
0.210
Why?
Health Care Costs
1
2020
79
0.210
Why?
Depression
3
2020
490
0.210
Why?
Health Services Accessibility
1
2020
106
0.210
Why?
Clinical Trials as Topic
2
2021
382
0.210
Why?
Office Visits
1
2019
14
0.200
Why?
Residence Characteristics
2
2019
211
0.200
Why?
Documentation
1
2019
26
0.200
Why?
Infection Control
1
2020
166
0.200
Why?
Treatment Outcome
6
2021
3788
0.190
Why?
Pediatrics
1
2019
48
0.190
Why?
Patient Acceptance of Health Care
1
2019
78
0.190
Why?
Societies, Medical
1
2020
202
0.190
Why?
Occupational Exposure
1
2018
27
0.190
Why?
Patient Participation
1
2018
51
0.190
Why?
Volunteers
1
2017
5
0.180
Why?
Prevalence
2
2018
533
0.180
Why?
Education, Distance
1
2017
16
0.180
Why?
Patient Transfer
1
2016
24
0.170
Why?
Risk Factors
4
2021
2549
0.170
Why?
Community Mental Health Services
1
2015
20
0.160
Why?
Health Status
3
2021
250
0.150
Why?
Housing
1
2013
16
0.140
Why?
Peer Group
1
2013
50
0.140
Why?
Drug Therapy, Combination
3
2020
264
0.130
Why?
Middle Aged
6
2020
11053
0.130
Why?
Vagus Nerve Stimulation
1
2012
5
0.130
Why?
Risk Assessment
3
2021
794
0.120
Why?
Randomized Controlled Trials as Topic
1
2013
357
0.120
Why?
Pilot Projects
2
2017
425
0.120
Why?
Obesity
2
2019
316
0.120
Why?
School Health Services
1
2011
19
0.120
Why?
Social Class
1
2011
72
0.120
Why?
Students
1
2011
39
0.120
Why?
Chronic Disease
1
2013
530
0.120
Why?
Chi-Square Distribution
1
2011
181
0.120
Why?
Retrospective Studies
1
2020
3303
0.120
Why?
Mexican Americans
1
2011
28
0.110
Why?
Age Factors
1
2013
912
0.110
Why?
Androstadienes
1
2010
6
0.110
Why?
Anti-Allergic Agents
1
2010
4
0.110
Why?
Rhinitis, Allergic, Seasonal
1
2010
7
0.110
Why?
Acetates
1
2010
25
0.110
Why?
Quinolines
1
2010
19
0.110
Why?
Puerto Rico
3
2014
15
0.100
Why?
Anxiety
2
2021
149
0.100
Why?
Respiratory Function Tests
1
2009
35
0.100
Why?
Music
1
2008
18
0.090
Why?
Aged
2
2020
9833
0.090
Why?
Logistic Models
2
2019
478
0.090
Why?
Emigration and Immigration
1
2006
17
0.090
Why?
Drug Combinations
2
2021
86
0.090
Why?
Forced Expiratory Volume
2
2019
11
0.090
Why?
Double-Blind Method
1
2008
541
0.080
Why?
Young Adult
3
2020
2198
0.080
Why?
Quality of Life
2
2021
604
0.080
Why?
Animals
1
2015
5125
0.080
Why?
Community-Based Participatory Research
2
2014
36
0.070
Why?
Review Literature as Topic
1
2021
12
0.060
Why?
Delphi Technique
1
2021
22
0.060
Why?
Substance-Related Disorders
2
2020
109
0.060
Why?
Qualitative Research
1
2021
112
0.060
Why?
London
1
2020
6
0.060
Why?
Terbutaline
1
2020
1
0.060
Why?
Consensus
1
2021
90
0.060
Why?
Guilt
1
2020
6
0.060
Why?
Markov Chains
1
2020
32
0.060
Why?
Health Care Rationing
1
2020
7
0.060
Why?
Self Administration
1
2020
36
0.060
Why?
Immunologic Deficiency Syndromes
1
2020
12
0.060
Why?
Efficiency
1
2020
20
0.060
Why?
Grief
1
2020
15
0.050
Why?
Suicide
1
2020
23
0.050
Why?
Drug-Related Side Effects and Adverse Reactions
1
2020
35
0.050
Why?
Community Health Services
1
2020
31
0.050
Why?
Cost-Benefit Analysis
1
2020
144
0.050
Why?
Social Media
1
2020
31
0.050
Why?
Spirituality
1
2020
54
0.050
Why?
Ambulatory Care
1
2020
86
0.050
Why?
Mindfulness
1
2020
41
0.050
Why?
ROC Curve
1
2019
154
0.050
Why?
Administration, Oral
1
2019
164
0.050
Why?
Healthcare Disparities
1
2020
75
0.050
Why?
Social Behavior
1
2020
107
0.050
Why?
Proportional Hazards Models
1
2020
379
0.050
Why?
Dose-Response Relationship, Drug
1
2020
524
0.050
Why?
Health Care Surveys
1
2019
76
0.050
Why?
Curriculum
1
2020
153
0.050
Why?
Communication
1
2020
118
0.050
Why?
Educational Status
1
2019
271
0.050
Why?
Smoking
1
2019
195
0.050
Why?
Odds Ratio
1
2019
328
0.050
Why?
Health Promotion
1
2020
183
0.050
Why?
Persuasive Communication
1
2017
1
0.050
Why?
Focus Groups
1
2017
90
0.040
Why?
Likelihood Functions
1
2017
31
0.040
Why?
Disease Progression
1
2020
843
0.040
Why?
Comorbidity
1
2019
555
0.040
Why?
Patient Outcome Assessment
1
2016
48
0.040
Why?
Monitoring, Physiologic
1
2017
101
0.040
Why?
Evidence-Based Practice
1
2016
82
0.040
Why?
Sinusitis
1
2019
178
0.040
Why?
Interviews as Topic
1
2015
138
0.040
Why?
Primary Health Care
1
2016
95
0.040
Why?
Schools
1
2014
33
0.040
Why?
Cotinine
1
2013
6
0.030
Why?
Tobacco Smoke Pollution
1
2013
7
0.030
Why?
Enkephalin, Methionine
1
1993
1
0.030
Why?
Allergens
1
2013
19
0.030
Why?
Saliva
1
2013
63
0.030
Why?
Vital Signs
1
2012
1
0.030
Why?
Killer Cells, Natural
1
1993
94
0.030
Why?
Work of Breathing
1
2012
7
0.030
Why?
Spirometry
1
2012
9
0.030
Why?
Feasibility Studies
1
2012
273
0.030
Why?
Acute Disease
1
2012
272
0.030
Why?
Administration, Intranasal
1
2010
26
0.030
Why?
Program Evaluation
1
2011
150
0.030
Why?
Stress, Psychological
1
2012
272
0.030
Why?
Illinois
1
2009
265
0.020
Why?
Body Mass Index
1
2009
435
0.020
Why?
Prospective Studies
1
2012
1809
0.020
Why?
Sensitivity and Specificity
1
2005
592
0.020
Why?
Vietnam
1
1993
8
0.010
Why?
In Vitro Techniques
1
1993
246
0.010
Why?
Alcoholism
1
1993
86
0.010
Why?
Analysis of Variance
1
1993
369
0.010
Why?
Veterans
1
1993
68
0.010
Why?
Mosnaim's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts Expand Description
_
Co-Authors Expand Description
_
Similar People Expand Description
_
Same Department Expand Description